Bethlehem, Pennsylvania-based B. Braun designed the device to reduce exposure to harmful chemicals. It aims to decrease infection risk in IV access for patients and healthcare providers.
The company says its device is the only needleless connector not made with Bisphenol A (BPA). This harmful chemical can potentially cause multi-organ toxicity. Instead, B. Braun designed CareSite Micro with a drug-resistant material. It helps reduce the risk of infections and drug exposure from stress cracks associated with material and drug incompatibility.
B. Braun developed the device to reduce the prevalence of hospital-acquired bloodstream infections. These are often associated with catheter insertions and remain a major cause of morbidity and mortality. CareSite Micro features a smooth, flat surface that allows proper disinfection. Its straight fluid path helps complete the flushing of blood and medications with a small flush volume. The company said this helps to reduce the risk of those hospital-acquired bloodstream infections.
“We are excited to introduce the CareSite Micro luer access device. Helping to reduce HA-BSIs and accidental drug exposure supports our commitment to the safety of the patients and providers we serve,” said Dr. Angela Karpf, VP medical affairs.
